1-6 of 6
John H. Baird
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR

Open Access
Clinical Trials & Observations
Kitsada Wudhikarn, Megan M. Herr, Min Chen, Michael J. Martens, John H. Baird, Lohith Gowda, Hemalatha G. Rangarajan, Muhammad Bilal Abid, Mohamed A. Kharfan-Dabaja, Kirsten M. Williams, Siddhartha Ganguly, Jo-Anne H. Young, Akshay Sharma, Giancarlo Fatobene, Tania Jain, Christopher G. Kanakry, Dipenkumar Modi, Natalie S. Grover, Baheyeldin Salem, Marjorie Vieira Batista, Paschalis Vergidis, Dwight E. Yin, Amer M. Beitinjaneh, Amar H. Kelkar, Taiga Nishihori, Jennifer Holter Chakrabarty, Usama Gergis, Melody Smith, Zeinab El Boghdadly, Christopher E. Dandoy, Hemant S. Murthy, Anna R. Huppler, Miguel-Angel Perales, Roy F. Chemaly, Joshua A. Hill, Marcie Riches, Jeffery J. Auletta
Journal: Blood Advances
Blood Adv (2025) 9 (21): 5460–5472.
https://doi.org/10.1182/bloodadvances.2025016141
Published: 2025
Includes: Supplemental data
Journal Articles

Polatuzumab vedotin in CNS lymphoma: proof-of-concept study for blood-brain barrier penetration

Open Access
Lei Gao, Avyakta Kallam, Geoffrey Shouse, John H. Baird, Stacy Pak, Yue Qin, Joo Y. Song, Guido Marcucci, Lucy Y. Ghoda, Claire Guillen, Suk-Joon Hyung, Ola M. Saad, Helen Davis, Randall Dere, Connie Lee Lee Batlevi, Joshua Meinert, L. Elizabeth E Budde, Alexey V Danilov, Alex F. F. Herrera, Larry W Kwak, Stephen J Forman, James K. Godfrey
Journal: Blood Advances
Blood Adv bloodadvances.2025017181.
https://doi.org/10.1182/bloodadvances.2025017181
Published: 2025
Includes: Supplemental data
Journal Articles

Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell lymphoma

Free
Esther H. Nie, Yi-Jiun Su, John H. Baird, Neha Agarwal, Sushma Bharadwaj, Wen-Kai Weng, Melody Smith, Saurabh Dahiya, May H. Han, Jeffrey E. Dunn, Lucas B. Kipp, David B. Miklos, Brian J. Scott, Matthew J. Frank
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1474–1486.
https://doi.org/10.1182/bloodadvances.2023011896
Published: 2024
Includes: Supplemental data
Journal Articles

Interferon-γ blockade in CAR T-cell therapy–associated macrophage activation syndrome/hemophagocytic lymphohistiocytosis

Free
Clinical Trials & Observations
Michael Rainone, Dat Ngo, John H. Baird, L. Elizabeth Budde, Myo Htut, Ibrahim Aldoss, Vinod Pullarkat
Journal: Blood Advances
Blood Adv (2023) 7 (4): 533–536.
https://doi.org/10.1182/bloodadvances.2022008256
Published: 2023
Journal Articles

Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma

Free
Clinical Trials & Observations
John H. Baird, David J. Epstein, John S. Tamaresis, Zachary Ehlinger, Jay Y. Spiegel, Juliana Craig, Gursharan K. Claire, Matthew J. Frank, Lori Muffly, Parveen Shiraz, Everett Meyer, Sally Arai, Janice (Wes) Brown, Laura Johnston, Robert Lowsky, Robert S. Negrin, Andrew R. Rezvani, Wen-Kai Weng, Theresa Latchford, Bita Sahaf, Crystal L. Mackall, David B. Miklos, Surbhi Sidana
Journal: Blood Advances
Blood Adv (2021) 5 (1): 143–155.
https://doi.org/10.1182/bloodadvances.2020002732
Published: 2021
Includes: Supplemental data
Journal Articles

A phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosis

Free
Clinical Trials & Observations
Jason Gotlib, John H. Baird, Tracy I. George, Cheryl Langford, Isabel Reyes, Justin Abuel, Cecelia Perkins, Kurt Schroeder, Prithviraj Bose, Srdan Verstovsek
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2264–2271.
https://doi.org/10.1182/bloodadvances.2019000152
Published: 2019
Includes: Supplemental data